<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
<title>Chinese Journal of Magnetic Resonance Imaging RSS feed</title>
<link>http://med-sci.cn/cgzcx/en/contents_list.asp?issue=202611</link>
<language>zh-cn</language>
<copyright>An RSS feed for Chinese Journal of Magnetic Resonance Imaging</copyright>
<item>
<title><![CDATA[Expert consensus on whole‑process safety management for MRI examinations in patients with in‑vivo implants (2026)]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.001</link>
<description><![CDATA[Magnetic resonance imaging (MRI) examination for patients with in vivo implants faces safety risks such as thermal effects, mechanical effects, and electromagnetic effects. Relevant guidelines at home and abroad have proposed inspection recommendations for some implants, but there is still a lack of systematic consensus on key clinical issues such as safety management, field strength selection, and non-compatible implant inspection conditions for different types of implants. Led by the Professional Committee of Radiation Intervention of the Chinese Nursing Association, more than 30 experts from imaging departments, evidence-based medicine and clinically related departments were organized. Based on the systematic review of the latest research evidence and relevant standard guidelines at home and abroad, combined with clinical practice, this consensus was formulated after several rounds of expert demonstration.The consensus puts forward 19 recommendations, with risk stratification assessment and multidisciplinary collaborative screening before examination, SAR parameter setting and real-time monitoring and emergency response during examination, programmed reexamination and follow-up of instruments after examination, personnel training and quality improvement of continuous management as the main line, aiming to provide operable practical guidance for medical institutions at all levels and effectively ensure the safety of patients <sup><sup>,</sup></sup> MRI examinations. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Effects of real-time fMRI neurofeedback targeting nucleus accumbens on brain-gut axis-related indicators in obese patients]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.002</link>
<description><![CDATA[<b>Objective</b>To investigate the effects of real-time functional magnetic resonance imaging neurofeedback (rtfMRI-NF) intervention targeting bilateral nucleus accumbens activity on eating behaviors and the regulation of brain–gut axis-related peripheral indicators in patients with obesity. <b>Materials and Methods</b>This study is a single-arm prospective self-controlled before-after interventional study. From December 2023 to December 2025, 39 obese patients were prospectively recruited for 3 weeks of neurofeedback intervention. Body mass index (BMI), restricted eating score, emotional eating score, external eating score, Yale Food Addiction Scale (YFAS), high-calorie food preference and health score, gastric inhibitory polypeptide (GIP), brain-derived neurotrophic factor (BDNF) and brain function indexes were collected before and after intervention. DPABI analysis software was used to preprocess the two groups of resting-state functional magnetic resonance imaging (rs-fMRI) data collected on the MATLAB 2022b platform and further calculate the fractional amplitude of low-frequency fluctuations (fALFF). SPSS paired sample<i> t</i> test was used to compare the changes of clinical scales and serum hormone levels in obese patients before and after intervention. SPM12 software package was used to perform paired sample<i> t </i>test on fALFF values of obese patients before and after intervention, and the correlation between fALFF values and clinical data in significantly different brain regions before and after intervention was evaluated. <b>Results</b>After intervention, BMI, emotional eating score, external eating score, YFAS, high-calorie food preference score and high-calorie food health score of obese patients decreased (<i>t</i>/<i>W </i>= 2.876, 5.430, 4.008, 3.022, 4.561, 3.122, <i>P</i> &lt; 0.05), while restrictive eating score increased (<i>t </i>= -4.866, <i>P </i>&lt; 0.05). After intervention, the fALFF values of right calcarine fissure, left dorsolateral superior frontal gyrus and left paracentral lobule in obese patients increased (<i>t </i>= 5.352 3, 4.545 8, 4.372 8, <i>P</i>&lt;0.05, Gaussian random field correction); the fALFF values of right posterior cingulate gyrus, right medial superior frontal gyrus and right middle frontal gyrus decreased (<i>t </i>= -4.688 4, -4.511 2, -4.927 7, <i>P </i>&lt; 0.05, Gaussian random field correction). The difference of fALFF value in the left dorsolateral superior frontal gyrus of obese patients before and after intervention was positively correlated with the difference of BDNF (<i>r </i>= 0.312, <i>P </i>= 0.024), and the difference of fALFF value in the right medial superior frontal gyrus was negatively correlated with the difference of restricted eating score (<i>r </i>= -0.334, <i>P </i>= 0.037). <b>Conclusions</b>rtfMRI-NF may improve the function of the default mode network, sensorimotor areas, and cognitive control regions in patients with obesity, elevate peripheral BDNF levels, and reduce maladaptive eating behaviors. These findings suggest a potential intervention mechanism underlying rtfMRI-NF for weight reduction and indicate that rtfMRI-NF may exert potential regulatory effects on brain–gut axis-related peripheral metabolic indicators in patients with obesity. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Alterations in white matter functional networks and functional covariance networks in children with self-limited epilepsy with centrotemporal spikes]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.003</link>
<description><![CDATA[<b>Objective</b>To investigate the alterations in white matter functional network and functional covariance network in children with self-limited epilepsy with centrotemporal spikes (SeLECTS) based on resting-state functional magnetic resonance imaging, and to evaluate their correlations with clinical variables such as disease duration, so as to provide clues for clinical intervention. <b>Materials and Methods</b>This retrospective secondary analysis included a total of 69 children diagnosed with SeLECTS at the Affiliated Hospital of Zunyi Medical University between January 2018 and January 2025, and 66 normal controls (HCs) matched for age, sex and years of education were recruited. K-means clustering was performed to identify WM functional networks, and the partition with the highest clustering stability was selected as the final network scheme. Functional connectivity (FC) and functional covariance connectivity (FCC) were calculated in the main frequency and sub-frequency bands. Bands were compared between the SeLECTS and the HCs, and the correlations between differential indicators and clinical variables were analyzed. <b>Results</b>Nine stable WM functional networks were identified by clustering analysis. Patients exhibited reduced functional integration in multiple networks, particularly in the medial corona radiata (WM1), Rolandic area (WM4), and cingulum (WM3) networks, with consistent reductions in FC and FCC across frequency bands (<i>t </i>= -3.284 to -2.687, <i>P </i>&lt; 0.001). Frequency-specific reductions in FCC were found between WM4/WM1 and the medial prefrontal network (WM9) in the Slow-4 and Slow-3 bands (<i>t</i>=-5.637 to -3.623, <i>P </i>&lt; 0.001), whereas increased FCC was detected between the ventral prefrontal (WM5) and orbitofrontal (WM8) networks (<i>t </i>= 3.846 to 3.876, <i>P </i>&lt; 0.001). Across the main frequency band, the FC of WM3-WM4 and the FCC of WM4-WM9 were negatively correlated with disease duration. <b>Conclusions</b>Children with SeLECTS exhibit bidirectional "decrease-increase" functional imbalances in white matter, featured by dysfunction of core frontoparietal fiber tract networks involving both the epileptogenic zone and functional alterations in distant brain regions. The abnormal remodeling of white matter functional connectivity and functional covariance connectivity provides neuroimaging evidence for understanding the pathophysiological mechanisms of the disease. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research on autism subtypes based on individualized extreme functional connectivity]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.004</link>
<description><![CDATA[<b>Objective</b>Autism spectrum disorder (ASD) is characterized by marked neurobiological heterogeneity. This study aimed to identify individual-level extreme functional connectivity features in patients with ASD using the Tolerance Interval (TI) method and to explore neurophysiological subtypes and their value for clinical diagnosis through cluster analysis. <b>Materials and Methods</b>This study is a retrospective study based on publicly available databases, which included 907 participants from the Autism Brain Imaging Data Exchange (ABIDE) database [451 in the ASD group and 456 in the healthy controls (HC) group]. Individual-level extreme functional connections were identified using the TI method. Multiple clustering algorithms were applied to evaluate the subtype structure within the ASD group, and the associations between subtype-specific features and Autism Diagnostic Observation Schedule (ADOS) scores were further examined. Finally, a support vector machine (SVM) classification model based on the fusion of multiple kernel functions was constructed to evaluate the clinical discriminative utility of the identified subtypes. <b>Results</b>ASD-related extreme functional connections identified by the TI method showed a dispersed distribution pattern, with hub nodes mainly located in the right inferior frontal gyrus, right middle frontal gyrus, and left superior temporal gyrus. Cluster analysis revealed two well-defined neurophysiological subtypes in ASD. Subtype 1 was characterized by widespread functional dysregulation involving multiple systems, and some extreme functional connections within this subtype were significantly associated with ADOS communication and stereotyped behavior scores (<i>P </i>&lt; 0.001). Subtype 2 showed highly concentrated network impairments, with abnormal features focused on core nodes of the salience network, including the basal ganglia, thalamus, and amygdala, as well as reduced connectivity within the default mode network. The classification accuracy for the overall ASD versus HC model was 56.4%, indicating limited discriminative ability of the unstratified model. In contrast, subtype-based stratification significantly improved classification performance: the accuracy was 61.8% for Subtype 1 and 83.7% for Subtype 2. <b>Conclusions</b>Subtyping based on extreme functional connectivity not only helps clarify the pathological mechanisms of ASD but also significantly improves the performance of machine learning models for computer-aided diagnosis of autism. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[An interpretable machine-learning model based on structural and metabolic features of the cortical-striatal-cerebellar circuit for predicting recurrence risk after recovery in adolescents with first-episode major depressive disorder]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.005</link>
<description><![CDATA[<b>Objective</b>To evaluate an interpretable machine learning model based on structural and metabolic features of the cortical-striatal-cerebellar (CSC) circuit for predicting recurrence after recovery in adolescents with first-episode major depressive disorder (MDD). <b>Materials and Methods</b>In this prospective study, 200 adolescents with first-episode MDD who had achieved recovery were consecutively enrolled. After follow-up and imaging quality control, 182 were included in the final analysis. The follow-up period was 24 months. Regional brain volumes within the CSC circuit were derived from structural MRI, and metabolite measures were obtained using magnetic resonance spectroscopy. Key imaging features were selected in the training set using univariable Cox regression followed by LASSO-Cox regression. Cox, CoxBoost, and random survival forest (RSF) models were constructed. Model performance was evaluated in the test set using the concordance index, time-dependent area under the receiver operating characteristic curve, Brier score, and area under the precision-recall curve. Shapley additive explanations (SHAP) were used to interpret the model predictions. <b>Results</b>Six key features were retained: L-ACC-Glx, L-ACC-NAA, R-ACC-mI, R-BG-sV, L-Tha-sV, and L-Tha-Cho. The RSF model showed comparatively favorable overall performance in the test set, with a concordance index of 0.768. The time-dependent areas under the receiver operating characteristic curve at 6, 12, and 24 months were 0.790 [95% confidence interval<i> </i>(<i>CI</i>): 0.695 to 0.873], 0.775 (95% <i>CI</i>: 0.674 to 0.859), and 0.742 (95% <i>CI</i>: 0.636 to 0.833), respectively, and the corresponding Brier scores were 0.119, 0.158, and 0.207. SHAP analysis showed that lower L-ACC-Glx, L-ACC-NAA, L-Tha-sV, and R-BG-sV, together with higher R-ACC-mI and L-Tha-Cho, were associated with a higher risk of recurrence. <b>Conclusions</b>Multimodal imaging features of the CSC circuit may provide objective imaging information for stratifying recurrence risk in adolescents who have recovered from a first episode of MDD. The interpretable RSF-based survival model may support individualized follow-up during recovery. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[A resting-state functional magnetic resonance imaging study of the relationship between cortical abnormal amplitude of low-frequency fluctuation and cognitive impairment in patients with vascular cognitive impairment]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.006</link>
<description><![CDATA[<b>Objective</b>To investigate the altered characteristics of whole-brain amplitude of low-frequency fluctuation (ALFF) in patients with vascular cognitive impairment (VCI) using resting-state functional magnetic resonance imaging (rs-fMRI), and to explore their correlation with cognitive function. <b>Materials and Methods</b>Fifty-six VCI patients and twenty-eight demographically matched normal controls (NC) were randomly enrolled. According to the scores of cognitive scales, the VCI group was subdivided into the vascular cognitive impairment-no dementia (VCIND) group (<i>n</i> = 28) and the vascular dementia (VaD) group (<i>n</i> = 28). Rs-fMRI data were collected from all participants. One-way analysis of variance and correlation analysis were used to explore the association between cortical ALFF values in different brain regions and cognitive function scores in VCI patients. <b>Results</b>One-way ANOVA revealed that, compared with the NC group, both the VCIND and VaD groups exhibited increased ALFF values in the right inferior temporal gyrus (<i>t</i> = 3.98, <i>P </i>&lt; 0.05; <i>t </i>= 3.57, <i>P </i>&lt; 0.05) and decreased ALFF values in the left posterior cingulate cortex (PCC) (<i>t</i> = 3.10, <i>P </i>&lt; 0.05; <i>t</i> = 3.08, <i>P </i>&lt; 0.05). After controlling for age, sex, and years of education, partial correlation analysis was conducted to examine the relationship between ALFF values of the different brain regions and cognitive performance in the VCIND and VaD groups. The results showed that ALFF values in the left PCC were significantly positively correlated with the number of correct responses in the Stroop color-word interference test (<i>r</i> = 0.781, <i>P</i> &lt; 0.001; <i>r</i> = 0.467, <i>P</i> = 0.014) and significantly negatively correlated with the difference between the completion time of Part B and Part A (<i>r </i>= -0.537, <i>P </i>= 0.004; <i>r </i>= -0.567, <i>P </i>= 0.002). <b>Conclusions</b>VCI patients present with abnormal spontaneous brain activity, which is mainly characterized by altered ALFF in key nodes of the default mode network. Notably, the functional decline of the left PCC is closely associated with the hypofunction of the left posterior cingulate cortex is closely associated with decreased executive function scores, suggesting that ALFF may serve as a potential neuroimaging biomarker for assessing disease severity and monitoring disease progression in VCI. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Correlation between asymmetric deep medullary veins sign and DTI-ALPS index in patients with acute ischemic stroke]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.007</link>
<description><![CDATA[<b>Objective</b>To investigate the correlation between the asymmetric deep medullary veins (ADMV) sign and the diffusion tensor imaging analysis along the perivascular space (DTI-ALPS) index in patients with acute ischemic stroke (AIS), and to evaluate the interaction between glymphatic microstructural impairment and venous drainage dysfunction in AIS. <b>Materials and Methods</b>This single‑center cross‑sectional observational study prospectively enrolled 92 patients with AIS. All subjects underwent MRI, including three-dimensional T1-weighted imaging (3D-T1WI), T2-weighted imaging (T2WI), fluid-attenuated inversion recovery (FLAIR), diffusion-weighted imaging (DWI), susceptibility-weighted imaging (SWI), and diffusion tensor imaging (DTI). The ALPS index was calculated based on DTI. According to SWI findings, patients with AIS were divided into the ADMV group (<i>n </i>= 49) and the non-ADMV group (<i>n </i>= 43). Clinical data were compared between the two groups. Univariate and multivariate linear regression analyses were performed to identify factors influencing the ALPS index and to examine its association with the ADMV sign. Multivariate regression Model Ⅰ was adjusted for age and sex; Model Ⅱ was adjusted for age, sex, NIHSS score, and hypertension; and Model Ⅲ was adjusted for age, sex, NIHSS score, hypertension, and diabetes. <b>Results</b>There was no significant difference in the ALPS index between the ipsilesional and contralesional sides in AIS patients (<i>t </i>= -0.027, <i>P </i>&gt; 0.05). The ALPS ratio (ipsilesional / contralesional) in the ADMV group was significantly higher than that in the non-ADMV group (<i>t </i>= 3.661, <i>P </i>&lt; 0.001). Univariate linear regression showed that age (<i>β </i>= 0.220, 95%<i> CI</i>: 0.000 to 0.005, <i>P </i>= 0.035), NIHSS score (<i>β </i>= 0.306, 95%<i> CI</i>: 0.003 to 0.016, <i>P </i>= 0.003), and ADMV (<i>β </i>= 0.360, 95%<i> CI</i>: 0.032 to 0.107, <i>P </i>&lt; 0.001) were associated with the ALPS ratio. After adjusting for confounders in multivariate regression models, ADMV remained independently associated with the ALPS ratio (Model Ⅰ: <i>β </i>= 0.286, 95%<i> CI</i>: 0.018 to 0.093, <i>P </i>= 0.005; Model Ⅱ: <i>β </i>= 0.304, 95%<i> CI</i>: 0.020 to 0.097, <i>P </i>= 0.003; Model Ⅲ: <i>β </i>= 0.310, 95%<i> CI</i>: 0.021 to 0.098, <i>P </i>= 0.003). Subgroup analysis demonstrated that the effect of ADMV on the ALPS ratio remained robust across different subgroups. <b>Conclusions</b>ADMV is independently associated with an elevated ALPS ratio, and the ALPS ratio is positively correlated with the severity of neurological impairment. These findings suggest that, in the AIS population, interpretation of the ALPS index should take SWI-assessed venous drainage status into account rather than regarding it solely as a specific marker of glymphatic function. Combined evaluation of these two imaging measures is expected to provide complementary reference information for assessing glymphatic alterations and stroke severity in patients with acute ischemic stroke. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Development and validation of an MRI radiomics model for the diagnosis of cerebral venous thrombosis]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.008</link>
<description><![CDATA[<b>Objective</b>To construct a fused model integrating multi-sequence MRI radiomic features, imaging features and clinical data, and to evaluate its diagnostic performance in cerebral venous sinus thrombosis (CVST), so as to provide quantitative references for early non‑invasive auxiliary diagnosis of CVST. <b>Materials and Methods</b>A retrospective analysis was conducted on 242 patients clinically suspected of CVST, randomly divided into a training set (169 cases) and a validation set (73 cases) at a 7∶3 ratio. Region of interest (ROI) delineation of the dural venous sinuses was manually performed on T2WI. The resulting ROI masks were then propagated to the co‑registered T1WI and Fluid‑attenuated inversion recovery (FLAIR) sequences via rigid registration. Pyradiomics was used to extract radiomics features, and highly correlated redundant features were removed based on Spearman correlation coefficients. Ten-fold cross-validation and least absolute shrinkage and selection operator (LASSO) were then employed to screen the remaining features. Meaningful imaging and clinical indicators were screened through univariate and multivariate logistic regression analyses. Single-sequence models and the fused model were constructed based on the LR algorithm. Model performance was evaluated using receiver operating characteristic (ROC) curves and the area under the curve (AUC). The DeLong test was used to compare differences in AUC, and decision curve analysis (DCA) was used to assess the clinical application value of the models. <b>Results</b>The fused model demonstrated the optimal performance, with an AUC of 0.974 [95% confidence interval<i> </i>(<i>CI</i>): 0.955 to 0.992] in the training set and an AUC of 0.946 (95% <i>CI</i>: 0.898 to 0.993) in the validation set. In the validation set, the sensitivity, specificity, accuracy, positive predictive value, and negative predictive value were 89.7%, 79.4%, 84.9%, 0.833, and 0.871, respectively, Brier = 0.095. The DeLong test showed that the AUC of the fused model was superior to that of the single-sequence models (<i>P </i>&lt; 0.05). Decision curve analysis demonstrated that this model provided clinical net benefit. <b>Conclusions</b>The fused model exhibits favorable diagnostic efficacy for CVST. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Application value of APT imaging combined with T2-FLAIR in non-contrast-enhanced diffuse gliomas]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.009</link>
<description><![CDATA[<b>Objective</b>To investigate the clinical value of amide proton transfer (APT) imaging combined with T2 fluid-attenuated inversion recovery (T2-FLAIR) sequence in grading diagnosis and prediction of isocitrate dehydrogenase (IDH) genotyping of non-enhancing diffuse gliomas, so as to provide non-invasive imaging evidence for precise diagnosis and treatment of such lesions. <b>Materials and Methods</b>A total of 120 patients with pathologically confirmed non-enhancing diffuse gliomas in our hospital from January 2021 to March 2025 were retrospectively enrolled. All patients underwent preoperative 3.0 T MRI examinations including APT and T2-FLAIR sequences. According to the World Health Organization (WHO) classification criteria, patients were divided into low-grade group (WHO grade 2, <i>n </i>= 56) and high-grade group (WHO grade 3-4, <i>n </i>= 64). Based on postoperative pathological IDH genotyping results, patients were classified into IDH-mutant group (<i>n </i>= 72) and IDH-wild-type group (<i>n </i>= 48). Two senior radiologists performed double-blinded image analysis. The APT value and relative signal intensity (rSI) of T2-FLAIR were measured and calculated, and the T2-FLAIR mismatch sign was assessed. Intra-class correlation coefficient (ICC) was used to evaluate inter-observer agreement. Independent-samples <i>t</i>-test and <i>χ</i><sup>2</sup>-test were adopted to compare imaging parameters among groups with different pathological grades and IDH genotypes. Receiver operating characteristic (ROC) curves were plotted to assess the diagnostic efficacy of single and combined imaging parameters. <b>Results</b>The intraclass correlation coefficient (ICC) values for APT value, T2 fluid-attenuated inversion recovery (T2-FLAIR) relative signal intensity (rSI), and maximum tumor diameter measured by two radiologists were 0.89, 0.92, and 0.90, respectively, indicating excellent inter-observer consistency. The APT value, T2-FLAIR rSI, and maximum tumor diameter were significantly higher in the high-grade glioma group than in the low-grade group (<i>t</i> = 18.723, 15.689, and 19.871, all <i>P</i> &lt; 0.001). The APT value was significantly higher in the isocitrate dehydrogenase (IDH) wild-type group than in the IDH-mutant group (<i>t</i> = 17.652, <i>P</i> &lt; 0.001), while the positive rate of the T2-FLAIR mismatch sign was significantly lower in the wild-type group (<i>χ</i><sup>2</sup> = 28.741, <i>P</i> &lt; 0.001). The combination of APT value and T2-FLAIR rSI yielded an area under the curve (AUC) of 0.942 (95% <i>CI</i>: 0.891 to 0.974) for diagnosing high-grade glioma, with a sensitivity of 90.63%, a specificity of 87.50%, and a cut-off value of 2.71, which was significantly superior to that of each single parameter. Furthermore, the combined model of APT value and T2-FLAIR mismatch sign achieved an AUC of 0.915 (95% <i>CI</i>: 0.856 to 0.953) for predicting IDH wild-type glioma, with a sensitivity of 85.42%, a specificity of 88.89%, and a cut-off value of 2.68, showing better diagnostic performance than individual indicators. <b>Conclusions</b>The combination of APT imaging and T2-FLAIR sequence integrates molecular metabolic and morphological information with complementary advantages. It can significantly improve the accuracy of grading diagnosis and the predictive performance of IDH genotyping for non-enhancing diffuse gliomas, and provide reliable non-invasive imaging evidence for individualized clinical treatment strategies. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Predicting tumor shrinkage patterns after neoadjuvant therapy in breast cancer using a stacking model integrating MRI habitat analysis and intratumoral microbiota]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.010</link>
<description><![CDATA[<b>Objective</b>To investigate the value of a multimodal stacking machine-learning model integrating MRI tumor habitat, peritumoral radiomics, intratumoral microbiota, and clinicopathological features for predicting the tumor shrinkage pattern (TSP) after neoadjuvant therapy (NAT) in breast cancer. <b>Materials and Methods</b>This multicenter ambispective cohort study included 285 patients with breast cancer, who were divided into a training set (<i>n </i>= 178), an internal validation set (<i>n </i>= 77), and an external validation set (<i>n </i>= 30). Using postoperative pathology as the reference standard, TSP was classified as concentric or non-concentric. Tumor radiomic features, including inter-subregion interaction features [volume ratio (VR); spatial dispersion (SD); transition-zone heterogeneity (TZH)], were extracted after habitat subregion partitioning. Together with peritumoral radiomics, clinicopathological features, and four derived microbial features, they were used to construct four base learners, which were integrated by stacking with logistic regression as the meta-learner. The incremental value of the microbial module was assessed using the DeLong test, net reclassification improvement (NRI), and integrated discrimination improvement (IDI), and habitat-microbiota associations were analyzed by Spearman correlation. <b>Results</b>The meta-model achieved AUCs of 0.872 in the training set, 0.846 in the internal validation set, and 0.839 in the external validation set, outperforming all individual base learners. After incorporation of the microbial module, the AUC increased by 0.061 (<i>P</i> &lt; 0.001), 0.054 (<i>P</i> = 0.004), and 0.058 (<i>P</i> = 0.003) in the training, internal validation, and external validation sets, respectively. A higher normalized bacterial burden (NBB) was independently associated with concentric shrinkage (OR = 2.68, <i>P </i>&lt; 0.001), whereas an imbalanced intratumoral bacterial distribution accompanied by endotoxin accumulation was associated with non-concentric shrinkage. The positive predictive value of concentric shrinkage for pathological complete response (pCR) remained stable at 76.5% to 78.4%. <b>Conclusions</b>This model enables noninvasive prediction of the NAT shrinkage pattern; the intratumoral microbiota provides an independent and reproducible incremental value across populations, offering a basis for individualized breast-conserving decision-making. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[The value of DWI-based virtual magnetic resonance elastography combined with the magnetic resonance severity index for early risk stratification in acute pancreatitis]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.011</link>
<description><![CDATA[<b>Objective</b>To investigate the value of the virtual shear modulus (μ<sub>Diff</sub>), a parameter derived from diffusion-weighted imaging (DWI)-based virtual magnetic resonance elastography (vMRE), combined with the magnetic resonance severity index (MRSI) for early risk stratification of acute pancreatitis (AP). <b>Materials and Methods</b>This was a single-center retrospective diagnostic study. A total of 140 patients with confirmed AP who underwent abdominal MRI at our institution between August 2024 and December 2025 were included. According to the 2012 revised Atlanta classification, 99 patients were classified as having mild acute pancreatitis (MAP) and 41 as having moderately severe or severe acute pancreatitis (MSAP/SAP). In addition, 38 healthy controls (HCs) were enrolled during the same period. DWI images acquired on a 3.0 T MRI system at b values of 200 and 1500 s/mm<sup>2</sup> were postprocessed to obtain μ<sub>Diff</sub> of the pancreatic parenchyma. Continuous variables among the three groups were compared using the Kruskal-Wallis test, and pairwise comparisons of μ<sub>Diff</sub> were performed using the Mann-Whitney <i>U</i> test with Bonferroni correction. Univariable and multivariable logistic regression analyses were performed to evaluate associated factors, and a combined model incorporating μ<sub>Diff</sub> and the MRSI was constructed. Discriminative performance was evaluated using receiver operating characteristic (ROC) curves and the area under the curve (AUC), with AUCs compared using the DeLong test. Decision curve analysis (DCA) and calibration curve were performed to assess potential clinical net benefit and agreement between predicted probabilities and observed outcomes, respectively. <b>Results</b>μ<sub>Diff</sub> progressively increased across the HC, MAP, and MSAP/SAP groups, with statistically significant differences in all pairwise comparisons (all <i>P</i> &lt; 0.05). Logistic regression analysis showed that both μ<sub>Diff</sub> and MRSI were independent predictors of MSAP/SAP. The DeLong test showed that the combined model based on μ<sub>Diff</sub> and MRSI had significantly better discriminative performance than either the μ<sub>Diff</sub>-only or MRSI-only model (<i>P</i> &lt; 0.05). The combined model achieved an AUC of 0.977 (95% <i>CI</i>: 0.957 to 0.997) for identifying MSAP/SAP. Its accuracy, sensitivity, specificity, positive predictive value, and negative predictive value were 94.29%, 92.68%, 94.95%, 88.37%, and 96.91%, respectively. DCA showed that the combined model provided a relatively high clinical net benefit across a broad range of threshold probabilities. <b>Conclusions</b>The DWI-based vMRE parameter μ<sub>Diff</sub> provides diffusion-derived quantitative mechanical information associated with AP severity. The combination of μDiff and MRSI improved the identification of MSAP/SAP in the present cohort and may serve as a noninvasive quantitative imaging approach for early clinical risk stratification and individualized management planning. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[MRI-Based multi-sequence 2.5D fusion deep learning model for preoperative prediction of lymphovascular space invasion in cervical cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.012</link>
<description><![CDATA[<b>Objective</b>To develop a deep learning (DL) model based on MRI multi-sequence 2.5D fused images for the preoperative prediction of lymphovascular space invasion (LVSI) in cervical cancer, and to evaluate its generalizability through internal cross-validation and external independent validation. <b>Materials and Methods</b>A total of 580 patients with cervical cancer who underwent radical hysterectomy from two centers were retrospectively enrolled and divided into a training set (<i>n </i>= 471, Center 1) and an external independent test set (<i>n</i> = 109, Center 2) according to the center of origin. Ten-fold cross-validation was used for model selection and internal evaluation within the training set. Axial images at the maximum tumor section were extracted from contrast-enhanced T1-weighted imaging (CE-T1WI) and T2-weighted imaging (T2WI), respectively. After isotropic resampling, coronal and sagittal images were obtained via multiplanar reconstruction, and three-channel 2.5D fusion images were constructed as input for the 2.5D DL model. DL features were extracted using a pretrained DenseNet169 model, and feature selection was performed via weighted elastic net logistic regression to build the 2.5D DL model. Independent clinical predictors were identified by univariable logistic regression analysis to construct a clinical model, and subsequently combined with the DL-Score to develop a nomogram. A 2D DL model and a radiomics model served as ablation controls. Model performance was assessed by the area under the receiver operating characteristic curve (AUC), and comparisons between models were performed using the DeLong test. <b>Results</b>The 2.5D DL model selected 48 key features (62.5% from CE-T1WI). It achieved a 10-fold cross-validation AUC of 0.812 and an AUC of 0.806 (95% <i>CI</i>: 0.726 to 0.886) in the external test set. Univariable logistic regression identified deep stromal invasion (≥ outer 1/3) and maximum lymph node short-axis diameter as independent predictors of LVSI. The standalone clinical model, 2D dual-sequence fusion model, and radiomics model yielded external test AUCs of 0.706, 0.694, and 0.777, respectively, all lower than that of the 2.5D DL model. The combined model achieved an external test AUC of 0.833 (95% <i>CI</i>: 0.758 to 0.907), with sensitivity improving from 34.8% (DL alone) to 60.9%, although the difference in AUC did not reach statistical significance (<i>P</i> = 0.333). Multi-threshold analysis showed that at a threshold of 0.30, the combined model attained a sensitivity of 80.4% and a negative predictive value of 82.7%. Calibration curves and decision curve analysis demonstrated good calibration and higher net clinical benefit for the combined model. <b>Conclusions</b>The 2.5D DL model based on MRI multi-sequence 2.5D fusion images can preoperatively predict LVSI in cervical cancer, with acceptable generalizability demonstrated through internal cross-validation and external independent validation. The integration of clinical variables markedly improves model sensitivity and clinical net benefit, providing a new imaging tool for preoperative noninvasive LVSI assessment in cervical cancer. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in brain structural and functional MRI in self-limited epilepsy with centrotemporal spikes: from focal discharges to brain network remodeling]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.013</link>
<description><![CDATA[Self-limited epilepsy with centrotemporal spikes (SeLECTS) is generally considered a benign childhood epilepsy syndrome. However, some affected children may develop impairments in language, attention, and executive functions. The underlying neural network mechanisms associated with these cognitive deficits remain incompletely understood. With advances in MRI, increasing attention has been directed toward structural, functional, and network-level alterations associated with SeLECTS. This review summarizes recent progress in structural MRI, diffusion MRI, functional MRI, and simultaneous electroencephalography-functional MRI studies of SeLECTS. The contributions of these imaging approaches to investigating the associations between focal epileptiform discharges and structural and functional brain network remodeling, as well as the associations between imaging phenotypes and cognitive impairment, were discussed. Current limitations, including small sample sizes, heterogeneity across studies, insufficient longitudinal investigations, limited multimodal integration, and the need for validation of imaging biomarker reliability, are also addressed. Future directions are proposed to improve understanding of the neural network mechanisms underlying SeLECTS and provide a reference for future investigations of potential imaging biomarkers. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in neuroimaging and analysis of developmental characteristics of pediatric obsessive‑compulsive disorder]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.014</link>
<description><![CDATA[Pediatric obsessive-compulsive disorder (POCD) is a well-defined and prevalent neurodevelopmental psychiatric disorder, characterized by recurrent obsessions and compulsions as its most prominent and typical symptoms. With the rapid advances in neuroimaging techniques, substantial progress has been made in exploring the neuropathological mechanisms underlying POCD. Multimodal imaging techniques including structural MRI (sMRI), functional MRI (fMRI), diffusion tensor imaging (DTI), and arterial spin labeling (ASL) perfusion imaging have been widely and maturely applied in POCD research. Cumulative evidence strongly suggests that the onset of POCD is highly associated with abnormalities in brain structure, function, and neural network connectivity. More importantly, childhood and adolescence represent the most critical and dynamic period of brain development; thus, neuroimaging abnormalities observed in patients with POCD exhibit distinct development-dependent features. This review systematically and hierarchically synthesizes the neuroimaging evidence of POCD: it first summarizes the aberrant patterns of brain structure, function and neural connectivity, and further analyzes the neurodevelopmental characteristics of POCD in the context of brain developmental trajectories. Meanwhile, this review identifies major limitations of existing studies: most investigations are cross-sectional and cannot disentangle the causal nature of brain alterations; there is mixing of evidence from adult OCD studies and heterogeneous samples; samples of young children under 8 years old are scarce; protocols for image acquisition and preprocessing are inconsistent; and neuroimaging biomarkers lack sufficient specificity. Future research directions are also proposed to facilitate further exploration of the neurobiological mechanisms and precision diagnosis and treatment of pediatric obsessive-compulsive disorder. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Neuroimaging research progress in migraine secondary to patent foramen ovale: Remodeling of pain modulation network and glymphatic system dysfunction]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.015</link>
<description><![CDATA[Patent foramen ovale (PFO) is significantly associated with migraine, particularly migraine with aura (MA), with a comorbidity rate substantially higher than that observed in the general population. Right-to-left shunt (RLS) facilitates paradoxical embolism, permits vasoactive substances to bypass pulmonary clearance, and induces oxidative stress, all of which act upon the trigeminovascular system (TVS). These pathophysiological processes contribute to dysregulation of the pain modulatory circuit, thereby triggering migraine. Multimodal neuroimaging techniques enable the in vivo detection of secondary pathological alterations associated with this disorder. Current research indicates that patients with migraine secondary to PFO exhibit abnormalities in gray matter volume, cortical morphology, and resting-state functional connectivity within pain modulatory circuits, suggesting remodeling of the central pain modulation network. Furthermore, diffusion tensor imaging analysis along the perivascular space (DTI-ALPS) has confirmed glymphatic system (GS) dysfunction in these patients, providing a critical mechanistic link in understanding PFO-associated migraine pathophysiology. However, current studies are limited by small sample sizes, heterogeneous findings, and an unclear understanding of PFO-specific effects on neural pain processing. This review summarizes the pain modulatory mechanisms and unique alterations in central pain modulation networks associated with PFO-related migraine. We provide neuroimaging evidence for structural and functional brain changes within pain modulatory circuits and GS dysfunction, aiming to advance personalized therapeutic strategies for this patient population, and highlight avenues for future investigations. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress on MRI-based evaluation of key brain network reorganization in patients with obesity after metabolic and bariatric surgery]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.016</link>
<description><![CDATA[Obesity is a major global public health problem, and its effects on brain structure and function, as well as the neuroplastic remodeling induced by bariatric metabolic surgery (BMS), have become a research focus in the field of neuroimaging. However, current studies remain limited by relatively small sample sizes, substantial heterogeneity in follow-up durations and research paradigms, a lack of direct comparisons between different surgical procedures, and insufficient evidence on the causal mechanisms linking brain network changes to metabolic and behavioral improvements, as well as on the prediction of long-term weight regain. Future research should integrate multimodal imaging, multi-omics, and artificial intelligence within standardized longitudinal studies to develop individualized models for predicting treatment response and weight-regain risk, thereby deepening the understanding of the central neural remodeling mechanisms of BMS and advancing precision management. This review systematically summarizes the application of MRI in studies of brain structure and function in obesity, analyzes structural abnormalities in patients with obesity—including reduced gray matter volume, cortical thinning, and impaired white matter microstructural integrity—as well as resting-state and task-based functional alterations, and focuses on the post-BMS reorganization of four key functional circuits: the reward circuit, the inhibitory control circuit, the sensory-driven circuit, and the affective and learning-memory circuit. This review aims to provide a reference for understanding the central neural mechanisms of BMS and for developing individualized precision intervention strategies. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in multiparametric magnetic resonance imaging for the assessment of the ischemic penumbra in acute ischemic stroke]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.017</link>
<description><![CDATA[The ischemic penumbra is the principal tissue target of reperfusion therapy in acute ischemic stroke. However, it is not a fixed anatomical region directly visualized by any single MRI sequence. Rather, it represents a dynamic tissue state shaped by ischemic duration, the severity of perfusion impairment, collateral compensation, and metabolic reserve. MRI assesses the penumbra indirectly through multiple surrogate markers. Diffusion-weighted imaging-fluid-attenuated inversion recovery (DWI-FLAIR) mismatch can support intravenous thrombolysis selection in patients with an unknown time of onset. Dynamic susceptibility contrast perfusion-weighted imaging and arterial spin labeling help identify hypoperfused tissue at risk. MRI-based oxygen extraction fraction measurements, amide proton transfer-weighted imaging, and sodium-23 magnetic resonance imaging (<sup>23</sup>Na MRI) provide exploratory information on oxygen metabolism, tissue acidosis, and ionic homeostasis, respectively. Intravoxel incoherent motion and advanced diffusion imaging seek to characterize heterogeneity within the ischemic core. Because these techniques reflect distinct aspects of ischemic pathophysiology, fixed thresholds and binary mismatch criteria cannot fully capture dynamic changes in tissue state. Current evidence is limited by inconsistent parameter thresholds and post-processing workflows and insufficient external validation of emerging techniques; future studies should emphasize standardization, multicenter validation, and multiparametric integration. This review integrates the clinical applications and pathophysiological basis of MRI surrogate markers, summarizes the technical principles and recent advances in multiparametric MRI assessment of the ischemic penumbra, and discusses the potential of multiparametric integration and artificial intelligence for tissue outcome prediction, with the aim of informing tissue-state assessment, imaging-based selection for reperfusion therapy, and related research in acute ischemic stroke. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress on normal reference values of white matter hyperintensities]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.018</link>
<description><![CDATA[White matter hyperintensity (WMH) is an important imaging marker of cerebral small vessel disease and is closely associated with cognitive decline, stroke, dementia, and increased risk of mortality. Traditional semi-quantitative scales such as the Fazekas scale are limited in their ability to precisely quantify individual differences and lack normative reference values adjusted for sex and age. In recent years, large-scale studies including the Rotterdam study, international multicenter cohorts, and Chinese population-based research have begun to establish normative reference values for WMH volume. Despite these initial advance, existing studies still face challenges such as limited population representativeness, a lack of data in the very elderly, and inconsistencies in technical standardization. Future efforts should focus on establishing more comprehensive WMH reference values based on multicenter, large-sample data, promoting technical standardization, developing region-specific reference values, and building a multimodal imaging-based comprehensive assessment system. It is important to achieve individualized and precise assessment of WMH burden. This article reviews the significance and methodologies of establishing normative WMH reference values, as well as the research progress and future directions in this field. It summarizes domestic and international research progress and existing challenges, aiming to provide a reference for clinicians and radiologists to determine whether WMH is normal, to offer new insights for individualized risk assessment, early identification, and precise prevention and treatment of cerebral small vessel disease, and to provide reference directions for future large-scale, multicenter standardized modeling and clinical translation research. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of coronary magnetic resonance angiography]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.019</link>
<description><![CDATA[Coronary heart disease (CHD) is one of the common cardiovascular diseases. Its mortality rate ranks first in the world. In recent years, the incidence of CHD has shown a significant upward trend, and the age of first onset has also shown a significant younger trend. Therefore, early diagnosis and intervention of CHD are of great significance for improving the long-term prognosis of patients. Coronary magnetic resonance angiography (CMRA) is a non-invasive and non-radioactive technique that can evaluate the condition of coronary artery without injection of contrast agent. Because of excellent soft tissue contrast, it can clearly observe and display the morphological changes of the coronary artery wall and overcome the artifact interference caused by wall calcification. Currently, CMRA has not been widely applied in clinical practice due to limitations such as excessively long acquisition time, poor image quality, unclear display of small distal vascular anatomical structures, and unclear display of coronary artery micro-lesions. This article systematically reviews imaging principles of CMRA technology, analyzes the current research limitations, and points out future research directions for corresponding optimization. The aim is to provide theoretical reference value for improving the accuracy of early clinical diagnosis and to offer new ideas and evidence for treatment decisions and prognostic assessments. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research advances in multimodal MRI for evaluating the efficacy of neoadjuvant therapy in breast cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.020</link>
<description><![CDATA[Among women worldwide, breast cancer is one of the most common malignant tumors, and neoadjuvant therapy (NAT) is one of the core treatment strategies for this disease; however, there are significant individual differences in the incidence of pathological complete response (pCR) following neoadjuvant therapy among patients with different molecular subtypes.Accurate, non-invasive dynamic assessment of treatment efficacy can assist clinicians in promptly adjusting treatment plans and evaluating patient prognosis. Multimodal MRI includes dynamic contrast-enhanced MRI (DCE-MRI), diffusion-weighted imaging (DWI), intravoxel incoherent motion (IVIM), diffusion kurtosis imaging (DKI), and synthetic magnetic resonance imaging (SyMRI). These sequences provide insights into tumor heterogeneity and treatment response from multiple perspectives, including perfusion, cell density, tissue microstructure, and quantitative relaxation properties. With ongoing advancements in the fields of radiomics and deep learning, the in-depth analysis and fusion of multimodal imaging data have been supported, and the accuracy and stability of treatment efficacy prediction models have been optimized. This paper systematically reviews current research progress on the application of multimodal MRI in evaluating the efficacy of NAT for breast cancer. It focuses on summarizing the biological significance and clinical value of functional MRI quantitative parameters, and outlines the technical approaches and existing limitations of using bioinformatics and deep learning for multimodal data integration.Building on this foundation, the paper outlines future research directions, including the standardization of imaging protocols, the conduct of large-scale prospective validation studies, the development of interpretable intelligent models, and the establishment of a multidimensional integrated evaluation system. This paper aims to provide a reference for subsequent research and clinical translation regarding the intelligent and systematic evaluation of the efficacy of neoadjuvant therapy for breast cancer. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress on the Kaiser score in breast MRI diagnosis]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.021</link>
<description><![CDATA[Breast cancer ranks first in incidence among female malignancies worldwide, and early, accurate diagnosis is a critical prerequisite for improving patient prognosis. The widely used breast imaging reporting and data system (BI-RADS) relies heavily on radiologists<sup><sup>,</sup></sup> subjective experience, with inherent limitations, including poor interobserver consistency and persistently high rates of unnecessary biopsies in BI-RADS category 4 lesions. The Kaiser score (KS) is a quantitative breast MRI assessment system constructed based on the chi-squared automatic interaction detection decision tree algorithm, integrating five core imaging features to generate an integer score ranging from 1 to 11 with corresponding standardized clinical management recommendations. Multiple studies have confirmed that KS significantly outperforms traditional BI-RADS classification in diagnostic accuracy, interobserver consistency, and reduction of unnecessary biopsies, demonstrating stable diagnostic performance across various clinical scenarios. However, a comprehensive summary and narrative evaluation of the evidence-based diagnostic value, clinical application limitations, and progress in artificial intelligence integration for KS is currently lacking. This article focuses on the scope of application, limitations, and AI integration progress of KS, analyzes current research deficiencies, and explores future development directions, aiming to provide a reference for precision breast lesion imaging differentiation and the standardized clinical promotion of KS assessment protocols. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of CT and MRI radiomics in predicting postoperative recurrence of hepatocellular carcinoma]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.022</link>
<description><![CDATA[Hepatocellular carcinoma (HCC) continues to face persistently high postoperative recurrence rates, which critically compromise long-term patient survival. Traditional prediction methods based on clinicopathological indicators are constrained by invasiveness, temporal lag, and inherent subjectivity. As a non-invasive quantitative image analysis technique, radiomics enables in-depth mining of tumor heterogeneity information and offers a novel avenue for preoperative, non-invasive prediction of post-surgical recurrence. However, existing reviews predominantly focus on unimodal or single-technology approaches, lacking a systematic synthesis of the evolutionary trajectory from conventional radiomics to deep learning and habitat analysis across both CT and MRI modalities. This review systematically summarizes the research progress of CT- and MRI-based radiomics in predicting HCC recurrence after resection, covering the current applications of intratumoral, peritumoral, multiphasic, and deep learning models. We contend that this field is transitioning from a "performance-driven" paradigm toward a "clinically problem-oriented" one. Future efforts should prioritize multicenter prospective validation, elucidation of imaging–biology mechanistic associations, development of fully automated end-to-end platforms, and assessment of decision impact, so as to facilitate the substantive translation of radiomics from laboratory research into individualized clinical practice. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of radiomics and deep learning in efficacy evaluation and prognosis prediction of liver malignant tumors]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.023</link>
<description><![CDATA[In recent years, radiomics and deep learning (DL) have experienced rapid development. Radiomics employs high-throughput extraction and analysis of quantitative features within medical images to non-invasively evaluate tumor therapeutic response and predict patient prognosis. DL based on convolutional neural networks further enhances the accuracy and automation of image analysis. Both approaches provide clinical support and new research directions for the systemic and local treatments of malignant liver tumors. Despite demonstrating extensive application prospects, both fields currently face significant challenges. This review systematically summarizes the progress of radiomics and DL across different treatment modalities for liver malignant tumors, clarifies their practical value and applicable scenarios in efficacy prediction and prognosis evaluation, summarizes current limitations in the field, and highlights future directions including multimodal fusion, dynamic prediction models construction, and multicenter large-sample prospective studies. The aim is to advance artificial intelligence-driven precision medicine for liver malignancies. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of radiomics in predicting treatment response and prognosis of hepatocellular carcinoma after TACE]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.024</link>
<description><![CDATA[Hepatocellular carcinoma (HCC) is one of the most common malignant tumors of the liver. Transcatheter arterial chemoembolization (TACE) serves as the first-line treatment for intermediate to advanced HCC; however, significant interindividual variability exists in treatment response and long-term prognosis. Radiomics enables non-invasive characterization of intratumoral and peritumoral microenvironmental features, and its integration with deep learning, habitat analysis, and multi-omics data facilitates the construction of predictive models. Nevertheless, current studies still face notable limitations in terms of standardization of image acquisition, feature reproducibility, prospective validation, and biological interpretability. Future efforts should focus on promoting deep integration of multimodal imaging and artificial intelligence, elucidating the biological mechanisms underlying radiomic features, and enhancing model generalizability through multicenter prospective cohort validation. This review systematically summarizes conventional imaging and clinical assessment approaches, as well as radiomics-based research advances in predicting TACE treatment outcomes in HCC patients, analyzes current challenges, and proposes future directions. It aims to provide imaging-based references for precise identification of TACE beneficiaries, early recognition of ineffective treatment, and individualized therapeutic decision-making, thereby facilitating the clinical translation of radiomics. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress on MRI assessment of extramural vascular invasion in rectal cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.025</link>
<description><![CDATA[Extramural vascular invasion (EMVI) is an independent risk factor for local recurrence, distant metastasis, and reduced overall survival in patients with rectal cancer (RC).Accurate preoperative MRI assessment is of considerable clinical value for individualized treatment decision‑making. This review summarizes recent advances in MRI-based assessment of RC EMVI, with a particular focus on the latest applications of radiomics and artificial intelligence (AI), and discusses their strengths and limitations. It aims to provide critical imaging evidence for formulating individualized clinical treatment strategies and to offer new diagnostic perspectives for precision medicine. Quantitative imaging and AI are shifting EMVI assessment from morphology-based description to precise quantification, offering more reliable imaging evidence for individualized management. Looking ahead, with the ongoing accumulation of multiparametric MRI data and continued advances in AI, the integration of radiomics and AI is likely to be further strengthened. In particular, the multidimensional integration of imaging, clinical, and biological information may represent a promising pathway to facilitate the clinical translation of precision medicine in RC, ultimately contributing to more effective and individualized patient care. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Application and advances of magnetic resonance-guided adaptive radiotherapy in uterine malignancies]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.026</link>
<description><![CDATA[Radiotherapy for uterine malignancies is undergoing a profound transformation from conventional image-guided approaches to magnetic resonance-guided adaptive radiotherapy (MRgART). By leveraging the superior soft-tissue contrast of magnetic resonance imaging (MRI), MRgART enables precise visualization of tumor targets and organs at risk (OAR), and employs an online adaptive workflow to adjust treatment plans in real time according to the daily anatomical variations, thereby improving target dose coverage while significantly reducing OAR doses. Previous reviews have predominantly focused on a single dimension either MR-Linac-based external beam radiotherapy or image-guided adaptive brachytherapy (IGABT) with few integrating the two within a unified framework. In contrast, this review jointly examines online MR-guided adaptive radiotherapy (oMRgRT) based on MR-Linac and MRI-guided IGABT as two complementary branches of a full-course adaptive strategy for uterine malignancies. Regarding oMRgRT, beyond delineating the dosimetric benefits of target margin reduction and OAR dose sparing, this review highlights the strategy of simultaneous integrated boost to involved lymph nodes and the indication criteria for oMRgRT as an alternative boost when brachytherapy is not feasible. Regarding IGABT, this review goes beyond conventional summaries of target volume concepts and dose-volume histogram parameters by incorporating longitudinal evidence from the EMBRACE study series on shifting patterns of failure and patient-reported outcomes, thereby extending the evaluation dimension to patient-centered comprehensive endpoints. In addition, the level of evidence for both technical approaches in cervical and endometrial cancer is graded according to the Oxford Centre for Evidence-Based Medicine (OCEBM) criteria to facilitate appraisal of their clinical credibility. Furthermore, this review explores how emerging technologies including functional MRI, artificial intelligence-assisted segmentation and plan optimization, and radiomics may drive the evolution from anatomy-based to biology-based adaptation. MRgART holds the promise of further improving the therapeutic ratio in radiotherapy for uterine malignancies and enhancing patient outcomes and quality of life through the integration of MRI-guided adaptation across the full course of external beam radiotherapy and brachytherapy. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in the clinical applications of multimodal quantitative MRI in sarcopenia]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.027</link>
<description><![CDATA[Sarcopenia is a progressive and generalized skeletal muscle disorder characterized by loss of skeletal muscle mass, reduced muscle strength, and impaired physical performance, and it is associated with increased risks of frailty, falls, fractures, perioperative complications, and mortality. As clinical assessment has shifted from muscle quantity alone toward integrated evaluation of muscle quality, strength, physical performance, and clinical outcomes, multimodal quantitative magnetic resonance imaging (MRI), which can noninvasively characterize muscle reserve, fat infiltration, tissue water content, microstructure, and metabolism, has gained increasing importance for phenotyping, treatment monitoring, and risk stratification. However, previous reviews have largely focused on MRI sequence principles or isolated quantitative parameters, with insufficient synthesis of how individual biomarkers address specific clinical questions, their evidence boundaries, and barriers to translation. This review aims to provide new perspectives for imaging research and refined clinical assessment of sarcopenia. We summarize the advantages of MRI assessment in sarcopenia, major quantitative MRI techniques and biomarkers, and their applications in diagnostic phenotyping, intervention monitoring, functional associations and exploratory risk stratification, comorbidity assessment, potential perioperative risk stratification, radiomics, and artificial intelligence. We also discuss current challenges in acquisition protocols, segmentation standards, reference thresholds, cross-platform consistency, and validation against clinical outcomes.Current evidence suggests that muscle volume, proton density fat fraction, and intermuscular adipose tissue have the greatest translational potential, whereas T2 relaxation time mapping, diffusion-weighted imaging, diffusion tensor imaging, and magnetic resonance spectroscopy provide complementary information on edema/inflammation, fiber microstructure, and energy metabolism but still require further standardization and longitudinal validation. Evidence linking MRI biomarkers to prospective hard clinical outcomes remains limited .We propose that future studies should establish stratified reference ranges for Chinese and Asian populations, harmonize multicenter acquisition, segmentation, and quality-control procedures, and integrate multiparametric MRI with muscle strength, physical performance, nutritional and inflammatory markers, and artificial-intelligence-based automated analysis. Prospective multicenter longitudinal studies should further determine the incremental value of these biomarkers for falls, hospitalization, perioperative complications, and mortality and clarify whether imaging changes translate into functional and clinical benefits, thereby promoting quantitative MRI from a research tool to an imaging biomarker that supports individualized clinical decision-making. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[High-field and ultra-high-field MRI of the musculoskeletal system: advances and challenges in transitioning from structural visualization to microstructure and composition quantification]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.11.028</link>
<description><![CDATA[Musculoskeletal (MSK) disorders represent one of the leading causes of functional impairment and disability worldwide, and biochemical and microstructural abnormalities at the tissue level often substantially precede macroscopic morphological damage. However, conventional magnetic resonance imaging (MRI) has inherent limitations in the quantitative assessment of early-stage pathological changes. By markedly improving the signal-to-noise ratio (SNR) and enabling the introduction and optimization of advanced contrast mechanisms, high-field (HF) and ultra-high-field (UHF) MRI are driving a paradigm shift in MSK imaging from structural visualization toward quantitative characterization of tissue microstructure, function, and biochemical composition. This review systematically summarizes advances in HF and UHF MRI for MSK imaging, covering the underlying physical principles, developments in hardware technology, and emerging quantitative imaging techniques, including T2 mapping, T1ρ imaging, quantitative susceptibility mapping, ultrashort echo time / zero echo time imaging, magnetic resonance fingerprinting, glycosaminoglycan chemical exchange saturation transfer imaging, the diffusion-weighted imaging sequence family, dynamic contrast-enhanced MRI, blood oxygen level-dependent imaging/arterial spin labeling, proton density fat fraction -based water-fat quantification, ²³Na MRI, and ³¹P magnetic resonance spectroscopy. The integration of artificial intelligence (AI) into accelerated image acquisition, super-resolution reconstruction, and automated diagnosis is further discussed. In addition, the unique clinical positioning and translational advantages of the domestic 5.0 T MRI system, which serves as a key technological bridge between 3.0 T and 7.0 T platforms, are highlighted. Meanwhile, this review objectively analyzes current challenges, including B₁ field inhomogeneity, specific absorption rate management, cross-field-strength quantitative standardization, and the lack of robust clinical evidence, and further discusses future directions in this rapidly evolving field. This review aims to provide a systematic reference for the clinical translation and technological innovation of HF and UHF MSK MRI in China. ]]></description>
<pubDate>Fri,20 Nov 2026 00:00:00  GMT</pubDate>
</item>
</channel>
</rss>
